Wednesday, 21 April 2021, 2:42 pm
Pfizer New Zealand has developed a patient support
website localised for Kiwi women with advanced breast
cancer, which will be launched on 20th April 2021 www.IBRANCE.co.nz.
This
new website has been designed to provide support for women
with hormone-receptor positive (HR+) and human epidermal
growth factor receptor 2 negative (HER2–) advanced breast
cancer1,2, and their carers.
Pfizer New Zealand
spokesperson Elise Kelly, the Business Unit Lead for
Oncology said: “We listened carefully to what patients
living with advanced breast cancer and their carers told us
about the support they wanted. The resulting IBRANCE NZ
website will in the near future include inspiring interviews
Press Release – Pfizer Pfizer New Zealand has developed a patient support website localised for Kiwi women with advanced breast cancer, which will be launched on 20th April 2021 www.IBRANCE.co.nz . This new website has been designed to provide support for women with hormone-receptor …
Pfizer New Zealand has developed a patient support website localised for Kiwi women with advanced breast cancer, which will be launched on 20th April 2021 www.IBRANCE.co.nz.
This new website has been designed to provide support for women with hormone-receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2–) advanced breast cancer1,2, and their carers.
How many? About two million people.
When? From July.
What about South Auckland?
“Approximately 40,000 courses are being allocated to Māori and Pacific providers who are working directly with older people, and we are also recognising the special circumstances of South Auckland,” Chris Hipkins said. “Anyone who lives in the Counties Manukau DHB area who is 65 and older or who has an underlying health condition is also in Group 2. This recognises that there are many border operations and MIQ facilities and their workforces based in this area.”
Any other categories?
Hipkins said two other categories were being explored. One is people who may need to get a vaccine on compassionate grounds. The other is a “national significance category”, which would include “groups who need a vaccine in order to represent New Zealand overseas”.
3.15pm: National created two versions of election review – report
A follow-up to a news story from earlier (see: 12.40pm) on National’s review into last year’s election loss.
Newshub’s Tova O’Brien has revealed that the National Party has created two versions of its election review. One is the full, unedited report while the other is a sanitised version with all the “gory details taken out”. Those are the words, according to O’Brien, of a party insider.
Newshub has been told that the party is frustrated with the closed process after being told to disclose everything during the review process. We can, almost certainly, expect more on this at 6pm.